Quality of Life of Children Ages 4-16 Years Old with Atopic Dermatitis using the Filipino Translation of Children’s Dermatology Life Quality Index Questionnaire (CDLQI) [Indeks ng Kalidad ng Buhay ng Pang-Dermatolohiya ng mga Bata (IKPaB)]
DOI:
https://doi.org/10.70552/pjaai.23.1.9863Keywords:
atopic dermatitis, quality of life, Children’s Dermatology Life Quality Index, Indeks ng Kalidad ng Buhay ng Pang-Dermatolohiya ng mga BataAbstract
Background: Atopic dermatitis (AD) is a chronic and relapsing skin condition known to have detrimental psychosocial impact in the pediatric population as well as a negative effect on their quality of life (QoL). This study determined the effect of AD on the QoL of patients ages 4-16 years old using the Filipino translation of Children’s Dermatology Life Quality Index Questionnaire [Indeks ng Kalidad ng Buhay ng Pang-Dermatolohiya ng mga Bata (IKPaB)].
Methodology: This investigation used a cross-sectional analytic study design. The IKPaB was administered to 50 patients with AD diagnosed within the context of a baseline medical history, physical examination and United Kingdom Working Party’s diagnostic criteria. Ten questions, covering 6 areas of daily activities (symptoms/feelings, leisure, school or holidays, personal relationships, sleep and treatment), were answered using a 4-point Likert scale score from 0 to 3. The total score yielded a minimum score of 0 and a maximum score of 30. Higher IKPaB score indicated a greater degree of QoL impairment. Statistical analysis was done using Z score and Mann Whitney U test.
Results: In the 6 variables measured, a small effect of AD on the symptoms and feeling and school holiday, while no effect on leisure, personal relationship, sleep and treatment were noted. No statistical variations were noted between life quality index of children when patients were grouped according to age, sex, body mass index, co-morbid conditions, parental education, employment, residence and family history of AD. Compounding all variables, mean ± SD score of 10.48 ± 5.05 showed a moderate effect on QoL.
Conclusions: AD of patients ages 4-16 years old had moderate effect on QoL as predicted by the IKPaB.
References
Ng MS, Tan S, Chan NH, Foong AY, Koh MJ. Effect of atopic dermatitis on quality of life and its psychosocial impact in Asian adolescents. Australas J Dermatol. 2018;59(2), e114–7. https://pubmed.ncbi.nlm.nih.gov/28836265 https://doi.org/10.1111/ajd.12632 DOI: https://doi.org/10.1111/ajd.12632
Campos ALB, Araújo FM, Dos Santos MAL, Dos, Santos AAS, Pires CAA. Impact of atopic dermatitis on quality of life of pediatric patients and their guardians. Rev Paul Pediatr. 2017;35(1):5–10. https://pubmed.ncbi.nlm.nih.gov/28977306 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5417799 https://doi.org/10.1590/1984-0462/;2017;35;1;00006 DOI: https://doi.org/10.1590/1984-0462/;2017;35;1;00006
Dionisio-Capulong R, Castor MAR, Kwong-Buizon SL, Fajardo-Nery V, Prevalence and risk factors of atopic dermatitis among Filipino children 0– 12 years old living in urban areas. Eur Acad Allergy Clin Immunol. 2016;71:528-91.
Smith S, Lee A, Blasczynski A, Fischer G. Attitude of Australian dermatologists to the use and safety of topical corticosteroids in pediatric atopic dermatitis. Australas J Dermatol. 2016;57(4):278-83. https://pubmed.ncbi.nlm.nih.gov/26391107 https://doi.org/10.1111/ajd.12402 DOI: https://doi.org/10.1111/ajd.12402
Marciniak J, Reich A, Szepietowski J. Quality of life of parents of children with atopic dermatitis. Acta Derm Venereol. 2017;97(6):711-4. https://pubmed.ncbi.nlm.nih.gov/28207075 https://doi.org/10.2340/00015555-2633 DOI: https://doi.org/10.2340/00015555-2633
Hon KL, Ng WGG, Kung JSC, Cheng NS, Ng DKK, Leung TF. Utility of pediatric allergic disease quality of life questionnaire for childhood eczema. 2019;181(2):290-5. https://pubmed.ncbi.nlm.nih.gov/30706447 https://doi.org/10.1111/bjd.17710 DOI: https://doi.org/10.1111/bjd.17710
Rea CJ, Tran KD, Jorina M, Wenren LM, Hawryluk EB, Toomey SL. Associations of eczema severity and parent knowledge with child quality of life in a pediatric primary care population. Clin Pediatr (Phila). 2018;57(13)1506-14. https://pubmed.ncbi.nlm.nih.gov/30008244 https://doi.org/10.1177/0009922818787295 DOI: https://doi.org/10.1177/0009922818787295
Holm JG, Agner T, Clausen ML, Thomsen SF. Quality of life and disease severity in patients with atopic dermatitis. J Eur Acad Dermatol Venereol. 2016;30(10):1760-7. https://pubmed.ncbi.nlm.nih.gov/27282435 https://doi.org/10.1111/jdv.13689 DOI: https://doi.org/10.1111/jdv.13689
Olsen JR, Gallacher J, Finlay AY, Piguet V, Francis NA. Quality of life impact of childhood skin conditions measured using the Children’s Dermatology Life Quality Index (CDLQI): a meta-analysis. Br J Dermatol. 2016;174(4):853–61. https://pubmed.ncbi.nlm.nih.gov/26686685 https://doi.org/10.1111/bjd.14361 DOI: https://doi.org/10.1111/bjd.14361
Chamlin SL. The psychosocial burden of childhood atopic dermatitis. Dermatol Ther. 2006;19(2):104–7. https://pubmed.ncbi.nlm.nih.gov/16669993 https://doi.org/10.1111/j.1529-8019.2006.00060.x DOI: https://doi.org/10.1111/j.1529-8019.2006.00060.x
Gonzales-Carait PKN, Genuino RF, Reyes KAZ, Dofitas B. Validation of a
Filipino translation of the children's dermatology life quality index text version.Acta Medica Philipp. 2020;54(3):270-7. https://doi.org/10.47895/amp.v54i3.1660 DOI: https://doi.org/10.47895/amp.v54i3.1660
Blome C, Radtke MA, Eissing L, Augustin M. Quality of life in patients with atopic dermatitis: disease burden, measurement, and treatment benefit. Am J Clin Dermatol. 2016;17(2):163–9. https://pubmed.ncbi.nlm.nih.gov/26818063 https://doi.org/10.1007/s40257-015-0171-3 DOI: https://doi.org/10.1007/s40257-015-0171-3
Lewis-Jones S. Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema. Int J Clin Pract. 2006;60(8):984-92. https://pubmed.ncbi.nlm.nih.gov/16893440 https://doi.org/10.1111/j.1742-1241.2006.01047.x
Carrera YL, Al Hammadi AA, Huang YH, Llamado LJ, Mahgoub E, Tallman, AM. Epidemiology, diagnosis, and treatment of atopic dermatitis in the developing countries of Asia, Africa, Latin America, and the Middle East: a review. Dermatol Ther (Heidelb). 2019;9(4):685-705. https://pubmed.ncbi.nlm.nih.gov/31650504 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6828917 https://doi.org/10.1007/s13555-019-00332-3 DOI: https://doi.org/10.1007/s13555-019-00332-3
Gabriel MTG, Barreiro ACN, Lavadia MAM, e al. A multi-center retrospective study on atopic dermatitis at the outpatient departments of Philippine Dermatological Society-accredited training institutions from 2007-2011. J Philipp Dermatol Soc. 2015;24(2):30-7.
Tsai T, Rajagopalan M, Chu C, et al. Burden of atopic dermatitis in Asia. J Dermatol. 2019;46(10):825-34. https://pubmed.ncbi.nlm.nih.gov/31436343 https://doi.org/10.1111/1346-8138.15048 DOI: https://doi.org/10.1111/1346-8138.15048
Lundberg L, Johannesson M, Silverdahl M, Hermansson C, Lindberg M. Health-related quality of life in patients with psoriasis and atopic dermatitis measured with SF-36, DLQI and a subjective measure of disease activity. Acta Derm Venereol. 2000;80(6):430–4. https://pubmed.ncbi.nlm.nih.gov/11243637 https://doi.org/10.1080/000155500300012873 DOI: https://doi.org/10.1080/000155500300012873
Halvorsen JA, Lien L, Dalgard F, et al. Suicidal ideation, mental health problems, and social function in adolescents with eczema: a population-based study. J Invest Dermatol. 2014;134(7):1847–54. https://pubmed.ncbi.nlm.nih.gov/24496238 https://doi.org/10.1038/jid.2014.70 DOI: https://doi.org/10.1038/jid.2014.70
Lewis-Jones MS, Finlay AY. The Children’s Dermatology Life Quality Index (CDLQI): initial validation and practical use. Br J Dermatol. 1995;132(6):942–9. https://pubmed.ncbi.nlm.nih.gov/7662573 https://doi.org/10.1111/j.1365-2133.1995.tb16953.x DOI: https://doi.org/10.1111/j.1365-2133.1995.tb16953.x
Hay RJ, Johns NE, Williams HC, et al. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol. 2014;134(6):1527–34. https://pubmed.ncbi.nlm.nih.gov/24166134 https://doi.org/10.1038/jid.2013.446 DOI: https://doi.org/10.1038/jid.2013.446
Dalgard FJ, Gieler U, Tomas-Aragones L, et al. The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries. J Invest Dermatol. 2015;135(4):984–91. https://pubmed.ncbi.nlm.nih.gov/25521458 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378256 https://doi.org/10.1038/jid.2014.530 DOI: https://doi.org/10.1038/jid.2014.530
Kim C, Park KY, Ahn S, et al. Economic impact of atopic dermatitis in Korean patients. Ann Dermatol. 2015;27(3):298–305. https://pubmed.ncbi.nlm.nih.gov/26082587 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466283 https:///doi.org/10.5021/ad.2015.27.3.298 DOI: https://doi.org/10.5021/ad.2015.27.3.298
Senra MS, Wollenberg A. Psychodermatological aspects of atopic dermatitis. Br J Dermatol. 2014;170(Suppl 1):38–43. https://pubmed.ncbi.nlm.nih.gov/24930567 https://doi.org/10.1111/bjd.13084 DOI: https://doi.org/10.1111/bjd.13084
Stores G, Burrows AB, Crawford C. Physiological sleep disturbance in children with atopic dermatitis: a case-controlled study. Pediatr Dermatol. 1998;15(4):264–8. https://pubmed.ncbi.nlm.nih.gov/9720687 https://doi.org/10.1046/j.1525-1470.1998.1998015264.x DOI: https://doi.org/10.1046/j.1525-1470.1998.1998015264.x
Balieva F, Kupfer J, Lien L, et al. The burden of common skin diseases assessed with the EQ5D™: a European multi-centre study in 13 countries. Br J Dermatol 2017;176(5):1170–8. https://pubmed.ncbi.nlm.nih.gov/28032340 https://doi.org/10.1111/bjd.15280 DOI: https://doi.org/10.1111/bjd.15280
Galli E, Gianni S, Auricchio G, Brunetti E, Mancino G, Rossi P. Atopic dermatitis and asthma. Allergy Asthma Proc. 2007;28(5):540–3. https://pubmed.ncbi.nlm.nih.gov/18034972 https://doi.org/10.2500/aap2007.28.3048 DOI: https://doi.org/10.2500/aap2007.28.3048
Cartledge N, Chan S. Atopic dermatitis and food allergy: a pediatric approach. Curr Pediatr Rev. 2018;14(3):171-9. https://pubmed.ncbi.nlm.nih.gov/29895253 https://doi.org/10.2174/1573396314666180613083616 DOI: https://doi.org/10.2174/1573396314666180613083616
Kantor R, Silverberg JI. Environmental risk factors and their role in the management of atopic dermatitis. Expert Rev Clin Immunol. 2017;13(1):15–26. https://pubmed.ncbi.nlm.nih.gov/27417220 Phttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216178 https://doi.org/10.1080/1744666X.2016.1212660 DOI: https://doi.org/10.1080/1744666X.2016.1212660
Ghaderi R, Saadatjoo A. Quality of life in patients with hand eczema as health promotion: a case control study. Acta Dermatovenerol Croat. 2014;22(1):32-9. https://pubmed.ncbi.nlm.nih.gov/24813839.
Ben Gashir MA, Seed PT, Hay RJ. Quality of life and disease severity are correlated in children with atopic dermatitis. Br J Dermatol. 2004;150(2):284–90. https://pubmed.ncbi.nlm.nih.gov/14996099 https://doi.org/10.1111/j.1365-2133.2004.05776.x DOI: https://doi.org/10.1111/j.1365-2133.2004.05776.x
Beattie PE, Lewis-Jones MS. A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases. Br J Dermatol 2006;155(1):145–51. https://pubmed.ncbi.nlm.nih.gov/16792766 https://doi.org/10.1111/j.1365-2133.2006.07185.x DOI: https://doi.org/10.1111/j.1365-2133.2006.07185.x
Lewis-Jones S. Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema. Int J Clin Pract. 2006;60(8):984–92. https://pubmed.ncbi.nlm.nih.gov/16893440 https://pubmed.ncbi.nlm.nih.gov/10.1111/j.1742-1241.2006.01047.x DOI: https://doi.org/10.1111/j.1742-1241.2006.01047.x
Šofranac M. Correlation between allergic rhinitis, asthma and atopic dermatitis in children. Pediatrics. 2008;121(Suppl 2); S91. https://doi.org/10.1542/peds.2007-2022G DOI: https://doi.org/10.1542/peds.2007-2022G
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Rhia Adrienne R. Reburiano, MD, Shirley Lam Kwong-Buizon, MD
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
